Skip to Content


Paul Gaita, quoting Rachel Sachs (Academic Fellow Alumna)
The Fix
May 18, 2017

Read the full article

From the article:

Gottlieb's position has earned cautious approval from medical industry observers like Washington University associate professor Rachel Sachs, who wrote, "As someone who understands the drug development process from all sides, [Gottlieb] will be more informed. I'm going to wait to judge to see what policy decisions he comes to. Hopefully, he has the agency's best interest at heart." More significantly, the pharmaceutical industry has applauded his appointment, "We look forward to working with Dr. Gottlieb in his new role," said Stephen J. Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America.

Read more here!

Read the full article

Tags

bioethics   fda   health care finance   health care reform   health law policy   rachel sachs   regulation   research